Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,303.02 +56.34 (+1.07%) Dow
39,847.25 +289.14 (+0.73%) Nasdaq
16,733.49 +222.31 (+1.35%) Bitcoin USD
65,022.15 +3,804.19 (+6.21%) CMC Crypto 200
1,373.46 +105.51 (+8.32%)
INO Jan 2025 2.500 call
- GuruFocus.com
Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Explore key financial outcomes and strategic updates from Inovio Pharmaceuticals Inc's first quarter of 2024, signaling robust progress and operational efficiency.
- PR Newswire
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the first quarter of 2024 and provided an update on recent company developments.
- PR Newswire
INOVIO Reports Inducement Grants Under Inducement Plan
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the "Inducement Plan").
